495 Basal cell carcinoma demonstrates a T-cell exclusion immune phenotype in contrast to other anti-PD-1 therapy responsive cutaneous malignancies

• Geoffrey Gibney,
• Ari VanderWalde,
• Joanne Xiu,
• Joseph Drabick,
• Gino In,
• Steven O’Day,
• Kelsey Poorman,
• W Korn

Affiliations

Geoffrey Gibney

Aff598 grid.213910.80000000119551644Lombardi Comprehensive Cancer Center Washington DC USA

Ari VanderWalde

Aff6 grid.417886.40000000106575612Amgen Inc. Thousand Oaks CA USA

Joanne Xiu

Caris Life Sciences, Phoenix, Arizona, USA

Joseph Drabick

Penn State Cancer Institute, Hershey, Pennsylvania, USA

Gino In

3Norris Comprehensive Cancer Center, Los Angeles, CA, USA

Steven O’Day

4John Wayne Cancer Institute, Santa Monica, CA, USA

Kelsey Poorman

2Caris Life Sciences, Phoenix, AZ, USA

W Korn

2Caris Life Sciences, Phoenix, AZ, USA